It differs structurally from native IGF-1 in two ways: an arginine substitution for glutamic acid at position 3 (the R3), and an additional 13-amino-acid extension at the N-terminus (the Long)
We do not know whether GLP-1 medications interact with endometriosis pathology in ways we have not considered
Global Initiative for Asthma (GINA)
You will talk through symptoms, goals, medical history, and what has or has not worked before
Once hydrated and glucose 5% of hepatocytes NAFL without hepatocyte damage NASH with hepatocyte damage Strong associations has been found with: obesity, diabetes, metabolic syndrome, PCOS, prolonged TPN, certain drugs Excess energy intake cause fat formation as vesicles inside hepatic cells that lead to steatosis Complications Fibrosis (3040%) Cirrhosis (10%) Hepatocellular carcinoma (HCC) Clinical Features -Mostly asymptomatic -RUQ pain, acanthosis nigricans -End-stage cirrhosis symptoms -Elevated LFT (25x), Ferritin (up to 60% cases) Diagnosis -Imaging: Ultrasonography, Ultrasonic elastography, MRE, Fibroscan - Liver biopsy for unexplained prolonged LFT elevation --- Treatment Strategies Lifestyle modification (510% weight loss) Caffeinated drip coffee fibrosis & HCC risk Omega-3 fatty acids intake Thiazolidinediones ( insulin sensitivity, inappropriate lipolysis) Vitamin E (not recommended more than 400Unites/day in diabetes) Bariatric surgery (effective in morbid obesity) Last resort: Liver transplant To view or add a comment, sign in Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-B pathway Liping Zhu 1, Jiakai Han 1, Rongrong Yuan 1, Lei Xue 1, Wuyan Pang 2 Affiliations Expand PMID: 29604956 PMCID: PMC5878418 DOI: 10.1186/s40659-018-0157-8 Abstract Background: Diabetic nephropathy (DN) is the leading cause of end-stage renal failure, contributing to severe morbidity and mortality in diabetic patients
